Bluejay Diagnostics BJDX
NASDAQ BJDX
$1.00 -0.03 (-3.38%)
As of: Sep 9, 2026 · 11:22 AM EDT

Bluejay Diagnostics (BJDX) Revenue (2022)

Bluejay Diagnostics' (BJDX) quarterly Revenue came in at $249040.0 in Q2 2022.

Analysis

Bluejay Diagnostics (BJDX) Revenue (2022) Analysis & Trends

Bluejay Diagnostics has disclosed Revenue across 1 years of filings, most recently posting $249040.0 for Q2 2022.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 GE HealthCare Technologies 30.07 Bn 27.96 Bn 2.18 Bn 5.30 Bn
2 Lantheus Holdings 6.57 Bn 5.98 Bn 241.86 Mn 388.18 Mn
3 Heartflow 4.12 Bn 3.74 Bn 53.19 Mn 64.08 Mn
4 Neogen 2.61 Bn 2.42 Bn 107.80 Mn 225.30 Mn
5 Butterfly Network 1.99 Bn 1.87 Bn 23.29 Mn 32.61 Mn
6 Ceribell 927.98 Mn 798.72 Mn 25.94 Mn 28.10 Mn
7 QuidelOrtho 883.12 Mn 759.72 Mn - -
8 Varex Imaging 778.85 Mn 679.65 Mn 76.70 Mn 210.50 Mn
9 Prenetics Global 338.80 Mn 279.75 Mn 30.20 Mn 46.49 Mn
10 Bluejay Diagnostics 2.08 Mn 2.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 249,040.00